Document is current
Any future updates will be listed below
-
Authors
Smith, Ruben http://orcid.org/0000-0001-7147-0112
Capotosti, Francesca http://orcid.org/0000-0003-2819-3206
Schain, Martin
Ohlsson, Tomas
Vokali, Efthymia
Molette, Jerome http://orcid.org/0009-0000-5381-5535
Touilloux, Tanja
Hliva, Valerie http://orcid.org/0000-0002-1252-0033
Dimitrakopoulos, Ioannis K.
Puschmann, Andreas
Jögi, Jonas
Svenningsson, Per http://orcid.org/0000-0001-6727-3802
Andréasson, Mattias
Sandiego, Christine
Russell, David S. http://orcid.org/0000-0002-9105-2943
Miranda-Azpiazu, Patricia
Halldin, Christer
Stomrud, Erik
Hall, Sara http://orcid.org/0000-0001-6585-9105
Bratteby, Klas http://orcid.org/0000-0003-0930-2390
Tampio L’Estrade, Elina
Luthi-Carter, Ruth
Pfeifer, Andrea
Kosco-Vilbois, Marie
Streffer, Johannes http://orcid.org/0000-0002-9387-5951
Hansson, Oskar http://orcid.org/0000-0001-8467-7286
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (MJFF-019169)
Vetenskapsrådet (2022-00775)
Knut och Alice Wallenbergs Stiftelse (2017-0383)
Alzheimerfonden (AF-980907)
Hjärnfonden (FO2021-0293)
Swedish Parkinson's Disease Association | Parkinsonfonden (1294/20, 1412/22)
Cure Alzheimer's Fund
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 6 October 2023
First Online: 27 October 2023
Competing interests
: R.S. has received a speaker fee from Roche. F.C., E.V., J.M., T.T., V.H., I.K.D., R.L.-C., A. Pfeifer, M.K.-V., and J.S. are employees of AC Immune SA. M.S. is an employee of Antaros Medical. A Puschmann receives reimbursement from Elsevier for his work as Associate Editor for Parkinsonism and Related Disorders. P.S. has received consultancy/speaker fees from Abbvie, Amylyx, Lundbeck, and Takeda. C.S. and D.S.R. are employees of Invicro, LLC. O.H. has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Genentech, Merck, Novartis, Novo Nordisk, Roche, Sanofi, and Siemens. T.O., J.J., M.A., P.M.-A., C.H., E.S., S.H., K.B., and E.T.L. report no disclosures.
